Bacthera Denmark A/S

Company:Bacthera Denmark A/S was incorporated on 7 August 2019. The company is 100% owned by Bacthera AG.CVR no:The company’s financial year covers the period 1 January 2023 – 31 December 2023.Registered address:Bacthera Denmark A/S (“Bacthera”) has the purpose to enable customers to bring life-changing Live Biotherapeutic treatments to patients. The services offered to customers spans across the full live biotherapeutic value chain, from technical development right through to cGMP manufacture and release of drug substance and drug product. Telephone:The organisation consists of highly skilled and committed employees who are working to establish new competences and expand operations. Bacthera is investing in the development of our employees and managers to ensure that competences development is Website:in line with growth ambitions.Hørsholm, 24 June 2024For Bacthera, the development of new science to support our customers is important, therefore Bacthera will protect knowhow through patenting where possible.Executive Board:Risk management is an integrated part of the way we run the company. Management is evaluating and addressing key risks on an ongoing basis and takes appropriate mitigation actions as required.To support of our manufacturing activities, production risk, product safety and quality assurance processes are carefully addressed in this connection.Bacthera is committed to our employees’ wellbeing and safety. Several initiatives have been implemented including preventive action, monitoring and follow-up on incidents.As Bacthera is an international company it is exposed to financial risks relating to currency and interest rate fluctuations, funding, liquidity, credit and counterparty risk. Legal risks may also arise as part of ordinary course of business.